CN Patent

CN1856572B — 抑制PARP活性的RNAi用于生产治疗癌症的药物的用途

Assigned to University of Sheffield · Expires 2013-11-06 · 13y expired

What this patent protects

本发明涉及抑制介导DNA链断裂修复的酶的活性的活性剂的用途，用于生产治疗介导同源重组的基因中缺陷导致的疾病的药物。

USPTO Abstract

本发明涉及抑制介导DNA链断裂修复的酶的活性的活性剂的用途，用于生产治疗介导同源重组的基因中缺陷导致的疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN1856572B
Jurisdiction
CN
Classification
—
Expires
2013-11-06
Drug substance claim
No
Drug product claim
No
Assignee
University of Sheffield
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.